Immunodiagnostic and therapeutic management of colon cancer using protein derived monoclonal antibody 31.1

Journal of Tumor Marker Oncology

Volumn 12, Issue 1, 1997, Pages 5-11

  Arlen, Myron ^a   Tsang, Al ^a   Marchildon, Greg ^a   Wang, Tommy ^a   Scherrer, Joseph ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1842357148     PISSN: 08863849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Arlen M, Tsang KY. The Nature of the Monoclonal Antibodies Derived from Immunogenic Membran Antigen of Human Colon Carcinoma Origin. J. Tumor Marker Oncology 5:31-319, 1990.
2. Arlen M, Tsang KY, Bartal A, Wolf J and Saric O. Monoclonal Antibodies to Immunoreactive Tumor Associated Antigen (TAA) from Human Colon Carcinoma. Journal of Tumor Marker Oncology 4:895-905, 1991.
3. Hollinshead AC, Elias EG, Arlen M et al. Specific Active Immunotherapy in Patients with Adenocarcinoma of the Colon Utilizing Tumor Associated Antigen. Cancer 56:480-489, 1985.
4. Arlen M., Hollinshead AC and Tsang KY. Identification and Characterization of a Colon Tumor Associated Antigen. Cancer Vaccine Monograph, New York Acad. Sciences, 1993.
5. Arlen M, Tsang KY. Monoclonal Antibodies and their Role in Modulation of the Immune Response. J. Surgical Oncology 54:103-108, 1993.
6. Ahlquist D. Candidate Stool Markers for Colorectal Cancer Screening: An Immunohistochemical Analysis. Proc. American Gastroent. Soc. San Diego, May 1995.
7. Tsang KY, Finch MD, Primus FJ and Schlom J. Human recombinant interleukin-6 enhances antibody-dependent cellular cytotoxicity of human tumor cells mediated by human peripheral blood mononuclear cells. Cancer Immunology and Immunotherapy, 34:9-16, 1991.
8. Mellstedt H, Frodin JE, Masucci G. Clinical Status of Monoclonal Antibodies in the Treatment of Colorectal Carcinoma. Oncology 3:25-32, 1989.
9. Reitmuller G, Schneider-Gadicke E, Gunter S, Schmiegel W et al. Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorecatal carcinoma. The Lancet 343:1177-1183, 1994.
10. Tsang KY, Kashmiri SVS, Defilippi R et al. A Human T-Cell Line Engineered to Secrete Chimeric Monoclonal Antibody. J. Immunotherapy 13:143-152, 1993.